Robust LC3B lipidation analysis by precisely adjusting autophagic flux

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Autophagic flux is crucial for cellular homeostasis and is often quantified using lipidated LC3B accumulation.
• Late-stage autophagy inhibitors are commonly employed to measure autophagic flux, aiding in the discovery of autophagy-activating compounds.

Purpose of the Study:

• To scrutinize the standard method for quantifying autophagic flux.
• To determine the optimal conditions for detecting autophagy activation and to validate a novel approach.

Main Methods:

• Comparison of bafilomycin A1 (BafA) and chloroquine for autophagic flux quantification.
• Assessment of rapamycin's effect on LC3B lipidation under varying BafA concentrations.
• Validation using a novel EP300 inhibitor to demonstrate autophagy activation.

Main Results:

• Chloroquine stimulates non-canonical LC3B-lipidation, making it unsuitable for flux quantification.
• Optimal autophagic flux increase with rapamycin requires BafA concentrations that create a bottleneck, not a complete block.
• A novel EP300 inhibitor activates autophagy in a mTORC1-dependent manner, validating the proposed method.

Conclusions:

• A sensitized background, rather than a complete block of autophagosome progression, is essential for accurately quantifying autophagic flux.
• This refined method allows for effective discrimination of autophagy activators based on cellular potency.
• The findings provide a more robust approach for autophagy research and drug discovery.